Within the EU’s 7th Framework programme, a grant of EUR 6 million has been awarded to the UNISEC Consortium, a joint effort to develop a new universal influenza vaccine involving three university partners, five national health institutes and four small and medium-sized enterprises. In this context, UNISEC partners Prof. E. Hak (Pharmacoepidemiology and Pharmacoeconomics) and Prof. E. Frijlink (Pharmaceutical Technology and Biopharmacy) of the Groningen Research Institute of Pharmacy will receive EUR 1.5 million; Prof. A. Huckriede (Molecular Virology) of the UMCG will receive EUR 0.5 million.
Combining leading expertise in influenza vaccine research and development with a proven track record, including participation in the successful EU FLUSECURE project, the UNISEC partners aim to develop a vaccine that offers both universal protection and commercial opportunity. In a single study, the three most promising vaccines are identified, further developed and clinically tested. The results will directly contribute to the development of a timely, longer-term, broader, more effective and cheaper universal vaccine for the prevention of annual and pandemic influenza.
The nominees for the 2022 Gratama Science Award have been announced: DrYuliya Hilevych (Faculty of Arts), Dr Hamidreza Kasaei (Faculty of Science and Engineering), and Dr Lieuwe Zijlstra (University College Groningen). The award is intended as an...
In his wind tunnel at Zernike Campus, Eize Stamhuis discovered the smart power of sea birds. But what could he do with the patent for promising wind turbine blades? An alliance with two pioneering entrepreneurs led to the Albatrozz start-up. From...
Maarten Loonen leads new polar expedition with scientists, journalists, policymakers and tourists.
The UG website uses functional and anonymous analytics cookies. Please answer the question of whether or not you want to accept other cookies (such as tracking cookies).
If no choice is made, only basic cookies will be stored. More information